This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Biotest Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jorg Schuttrumpf
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
less than a year
CEO ownership
n/a
Management average tenure
3.7yrs
Board average tenure
3.3yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Jorg Schuttrumpf's remuneration changed compared to Biotest's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2025
n/a
n/a
-€24m
Dec 31 2024
n/a
n/a
€26m
Sep 30 2024
n/a
n/a
€69m
Jun 30 2024
n/a
n/a
€164m
Mar 31 2024
n/a
n/a
€177m
Dec 31 2023
€707k
€294k
€127m
Sep 30 2023
n/a
n/a
€91m
Jun 30 2023
n/a
n/a
-€10m
Mar 31 2023
n/a
n/a
-€47m
Dec 31 2022
€737k
€294k
-€32m
Compensation vs Market: Insufficient data to establish whether Jorg's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: Jorg's compensation has been consistent with company performance over the past year.
CEO
Jorg Schuttrumpf (51 yo)
less than a year
Tenure
€707,000
Compensation
Dr. Jorg Schuttrumpf is CEO & Chairman of Management Board of Biotest Aktiengesellschaft from May 28, 2025. Dr. Schuttrumpf serves as Chief Scientific Innovation Officer of Grifols, S.A. from 2024. Dr. Sch...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Jorg Schuttrumpf
CEO & Chairman of Management Board
less than a year
€707.00k
no data
Dirk Schuck
Employee Representative Member of Supervisory Board
3.7yrs
€44.00k
no data
Monika Buttkereit
Head of Investor Relations
no data
no data
no data
Christina Erb
Head of Corporate HR
10.1yrs
no data
no data
3.7yrs
Average Tenure
Experienced Management: BIO's management team is considered experienced (3.7 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Dirk Schuck
Employee Representative Member of Supervisory Board
3.3yrs
€44.00k
no data
Raimon Grifols Roura
Member of Supervisory Board
2.3yrs
€29.00k
no data
Bernhard R. Ehmer
Chairman of the Supervisory Board
3.3yrs
€132.00k
no data
Gernot Hebestreit
Shareholder Representative Member of Supervisory Board
less than a year
no data
no data
David Bell
Shareholder Representative Member of Supervisory Board
3.3yrs
€44.00k
no data
Jurgen Heilmann
Employee Representative Member of Supervisory Board
14yrs
€44.00k
no data
3.3yrs
Average Tenure
62.5yo
Average Age
Experienced Board: BIO's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2025/09/03 03:30
End of Day Share Price
2025/06/06 00:00
Earnings
2025/03/31
Annual Earnings
2024/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biotest GmbH & Co. KGaA is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.